NADAC acquisition cost data for PROMETHAZINE 50 MG TABLET. This is a generic medication, typically more affordable than brand-name equivalents.
| NDC | NADAC/Unit | Effective Date | Type |
|---|---|---|---|
| 00591531901 | $0.0796 | 2022-12-21 | Rx |
| 00781183201 | $0.0796 | 2022-12-21 | Rx |
| 10702000401 | $0.0796 | 2022-12-21 | Rx |
| 53746052201 | $0.0796 | 2022-12-21 | Rx |
| 57664010988 | $0.0796 | 2022-12-21 | Rx |
| 65162052210 | $0.0796 | 2022-12-21 | Rx |
| 68001016300 | $0.0796 | 2022-12-21 | Rx |
| 68382004201 | $0.0796 | 2022-12-21 | Rx |
| 00591531901 | $0.0796 | 2022-12-21 | Rx |
| 00781183201 | $0.0796 | 2022-12-21 | Rx |
Generic: Promethazine HCl | Manufacturer: Overall
| Year | Total Spending | Claims | Beneficiaries | Cost/Unit |
|---|---|---|---|---|
| 2019 | $17.4M | 1,495,922 | 565,436 | $0.3192 |
| 2020 | $17.1M | 1,431,996 | 504,734 | $0.2969 |
| 2021 | $16.5M | 1,417,603 | 515,884 | $0.2772 |
| 2022 | $17.5M | 1,431,004 | 538,484 | $0.2851 |
| 2023 | $16.5M | 1,396,951 | 523,738 | $0.2694 |
The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.
Read our full methodology or contact us with corrections.
Explore More Data Tools
For adjacent public-data tools, methodology notes, and network updates, visit DataPeek Facts.